![Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application | Journal of Medicinal Chemistry Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.0c00249/asset/images/large/jm0c00249_0005.jpeg)
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application | Journal of Medicinal Chemistry
![Hydrogenation and Redox Isomerization of Allylic Alcohols Catalyzed by a New Water-Soluble Pd–tetrahydrosalen Complex | Organometallics Hydrogenation and Redox Isomerization of Allylic Alcohols Catalyzed by a New Water-Soluble Pd–tetrahydrosalen Complex | Organometallics](https://pubs.acs.org/cms/10.1021/om400555u/asset/images/medium/om-2013-00555u_0011.gif)
Hydrogenation and Redox Isomerization of Allylic Alcohols Catalyzed by a New Water-Soluble Pd–tetrahydrosalen Complex | Organometallics
Surface Probing by Fragment-Based Screening and Computational Methods Identifies Ligandable Pockets on the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase | Journal of Medicinal Chemistry
![Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife](https://iiif.elifesciences.org/lax:79747%2Felife-79747-fig1-v3.tif/full/full/0/default.jpg)
Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife
Toward the Prediction of Water Exchange Rates in Magnetic Resonance Imaging Contrast Agents: A Density Functional Theory Study | The Journal of Physical Chemistry A
![The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression | eLife The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression | eLife](https://iiif.elifesciences.org/lax:77072%2Felife-77072-fig1-figsupp1-v1.tif/full/full/0/default.jpg)
The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression | eLife
![Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife](https://iiif.elifesciences.org/lax:79747%2Felife-79747-fig6-v3.tif/full/1500,/0/default.jpg)
Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife
![Energies | Free Full-Text | Induction Motor Bearing Fault Diagnosis Based on Singular Value Decomposition of the Stator Current Energies | Free Full-Text | Induction Motor Bearing Fault Diagnosis Based on Singular Value Decomposition of the Stator Current](https://www.mdpi.com/energies/energies-16-03303/article_deploy/html/images/energies-16-03303-g001.png)
Energies | Free Full-Text | Induction Motor Bearing Fault Diagnosis Based on Singular Value Decomposition of the Stator Current
![Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ... Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...](https://pubs.acs.org/cms/10.1021/acs.jmedchem.6b00544/asset/images/medium/jm-2016-005448_0002.gif)
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects | Journal of Medicinal ...
![Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife](https://iiif.elifesciences.org/lax:79747%2Felife-79747-fig4-v3.tif/full/1500,/0/default.jpg)
Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife
![Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS | eLife](https://iiif.elifesciences.org/lax:79747%2Felife-79747-fig3-v3.tif/full/1500,/0/default.jpg)